12:00 AM
 | 
Feb 18, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Human neural stem cells: Interim Phase I/II data

Additional data from the first cohort of patients with thoracic neurological injuries (n=3) in an open-label, Swiss Phase I/II trial showed that improvements in sensory function observed in 2 patients at 6 months after transplantation with 20 million HuCNS-SC cells into the spinal cord have persisted to 12 months, with 1 patient converting from a complete to an incomplete injury. The company said the third patient remains...

Read the full 312 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >